State of the art of leadless pacing.
| Autor: | Sperzel J; Department of Cardiology, Kerckhoff Heart and Thorax Center, Bad Nauheim, Germany j.sperzel@kerckhoff-klinik.de., Burri H; Cardiology Service, University Hospital of Geneva, Geneva, Switzerland., Gras D; Department of Cardiology, Nouvelles Cliniques Nantaises, Nantes, France., Tjong FV; Department of Cardiology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands., Knops RE; Department of Cardiology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands., Hindricks G; Heart Center, University Leipzig, Leipzig, Germany., Steinwender C; Dept. of Cardiology, Linz General Hospital, Johannes Kepler University Linz, Linz, Austria., Defaye P; Arrythmia Unit, Cardiology Department, University Hospital of Grenoble, Grenoble, France. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology [Europace] 2015 Oct; Vol. 17 (10), pp. 1508-13. Date of Electronic Publication: 2015 May 29. |
| DOI: | 10.1093/europace/euv096 |
| Abstrakt: | Despite undisputable benefits, conventional pacemaker therapy is associated with specific complications related to the subcutaneous device and the transvenous leads. Recently, two miniaturized leadless pacemakers, Nanostim™ (St. Jude Medical) and Micra™ (Medtronic), which can be completely implanted inside the right ventricle using steerable delivery systems, entered clinical application. The WiCS™-cardiac resynchronisation therapy (CRT) system (wireless cardiac stimulation for CRT, EBR Systems) delivers leadless left ventricular endocardial stimulation for cardiac resynchronization. In addition to obvious cosmetic benefits, leadless pacing systems may have the potential to overcome some complications of conventional pacing. However, acute and long-term complications still remains to be determined, as well as the feasibility of device explantation years after device placement. (© The Author 2015. Published by Oxford University Press on behalf of the European Society of Cardiology.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|